Simultaneous analysis of sputum and serum biomarkers in adult asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Serum ECP in comparison to sputum ECP measurements in symptomatic and asymptomatic subjects with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Cell profile in bronchoalveolar lavage (BAL) and function testing in narghile (waterpipe) smokers Source: Eur Respir J 2006; 28: Suppl. 50, 466s Year: 2006
Airway wall eosinophilia in severe asthmatic children: predictive values for noninvasive tests Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006
Cellular profiles of induced sputum and bronchoalveolar lavage in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Elevation of surfactant protein A in plasma and sputum in cigarette smokers Source: Eur Respir J 2011; 38: 277-284 Year: 2011
Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007
Metabolite markers identify pneumonia better in serum than sputum or broncho-alveolar lavage fluid Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020
Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Gender differences in 5- and 12/15-lipoxygenases products in bronchoalveolar lavage fluid from healthy never-smokers, smoker and COPD patients Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis Source: Annual Congress 2012 - Sarcoidosis Year: 2012
Physiological correlations between urea and total protein in breath condensate, bronchoalveolar lavage fluid and serum (animal model) Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001